Information Provided By:
Fly News Breaks for November 12, 2018
AKBA, KERX
Nov 12, 2018 | 08:36 EDT
As previously reported, Raymond James analyst Reni Benjamin downgraded Keryx (KERX) to Market Perform from Outperform as he sees shares trading in-line with the market until the merger with Akebia (AKBA) is complete. The potential merger with Akebia is likely to go through by year-end, Benjamin contends. The merged company is likely to become "a fully-integrated renal powerhouse," the analyst added.
News For KERX;AKBA From the Last 2 Days
There are no results for your query KERX;AKBA